Scott Brun

1.7k citations
20 papers · 1.5k · 1 hit paper · h-index 11

Impact in

  • Virology top 1%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions
    • COVID-19 Clinical Research Studies

Papers in

    • HIV/AIDS drug development and treatment 12
    • HIV/AIDS Research and Interventions 4
    • HIV Research and Treatment 5

Scott Brun

19 papers receiving 1.4k citations

Scott Brun's Hit Papers

Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection 2002 · 573 citations
5730+8+16Years since publication100200300400500

Peers

Scott Brun
Comparison fields: 5 of 74
  • Virology 621
  • Infectious Diseases 1.1k
  • Emergency Medicine 262
  • Hepatology 82
  • Ophthalmology 40
Replace Scott C. Brun with:
Scott C. Brun United States
Sandy K Griffith United States
Michael Sension United States
Martin S. Rhee United States
Sharon L. Benoit United States
Jane Yeo United Kingdom
Richard Stryker United States
Douglas J. Manion United States
Stephen L. Becker United States
James Stanford United States
Scott Brun relative to Scott C. Brun United States Scott C. Brun's profile →
Citations per field
00.5×2×3.3×
Scott C. Brun · 1×
Citations per year

Countries citing papers authored by Scott Brun

Since Specialization
Citations

This map shows the geographic impact of Scott Brun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Brun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Brun more than expected).

Fields of papers citing papers by Scott Brun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Brun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Brun. The network helps show where Scott Brun may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott Brun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott Brun Line = papers co-authored together Scott Brun links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection
Hit paper breakdown →
2002573
2 2001204
3 2004187
4 2002134
5 200578
6 200377
7 200458
8 199751
9 200525
10 199918
11 200718
12 200710
13 19998
14 20228
15
Kaletra (Lopinavir/ritonavir) Therapy in Single Protease Inhibitor Experienced Patients: 144-Week Follow-up
20017
16 20237
17 20244
18 20062
19
Assessment of the pharmacokinetic interaction between lopinavir/ritonavir and nevirapine in HIV-infected pediatric subjects
20001
20
Assessment of the pharmacokinetic interaction between ABT-378/ritonavir and efavirenz in healthy volunteers and in HIV + subjects
20001

About Scott Brun

Scott Brun is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Pediatrics, Perinatology and Child Health and Ophthalmology, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (4 papers), HIV-related health complications and treatments (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Ocular Infections and Treatments (2 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Virology (621 citations), Infectious Diseases (1.1k citations), Emergency Medicine (262 citations), Hepatology (82 citations) and Ophthalmology (40 citations). Scott Brun has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Martin S. King, Eugene Sun, Barry M Bernstein, Anthony J. Japour, David Wayne Johnson, Peter Jerome Ruane, Margaret Johnson, RICHARD G. LALONDE, Sharon Lynn Walmsley and José Ramón Arribas. Their work appears in journals such as HIV Clinical Trials, The Journal of Infectious Diseases, Retina, Ophthalmology and Future Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact